Targeting PIKfyve-driven lipid metabolism in pancreatic cancerCaleb Cheng, Arul M. Chinnaiyan, Jing Hu et al.|Nature|2025Cited by 37
Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapyYi Bao, Arul M. Chinnaiyan, Yuanyuan Qiao et al.|Proceedings of the National Academy of Sciences|2023Cited by 31
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean C. Tien, Arul M. Chinnaiyan, Jie Luo et al.|Cell Reports Medicine|2024Cited by 28
Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancerTongchen He, Arul M. Chinnaiyan, Caleb Cheng et al.|Proceedings of the National Academy of Sciences|2024Cited by 22
Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literatureAnandi Lobo, Rohit Mehra, Guillermo G Diego et al.|Histopathology|2024Cited by 14